Motif ID	Motif Logo	Scanned Score Distribution	Frequency of Motif	Replicability Score	Evolutionary Conservation Score	Gene Targets	Gene Ontology of CpGMM targets
CG_ffipsc69_promoter_p_PM_14_34_11			2	0.4	4.14E-05	PRMT1, ACR, PNMT, PPIF, FUT8, ANO6	N-glycan fucosylation [BP], amidase activity [MF], snoRNP binding [MF], glycoprotein 6-alpha-L-fucosyltransferase activity [MF], acrosome matrix dispersal [BP], phenylethanolamine N-methyltransferase activity [MF], [cytochrome c]-arginine N-methyltransferase activity [MF], phosphatidylserine exposure on blood platelet [BP], regulation of proton-transporting ATPase activity, rotational mechanism [BP]
CG_ffipsc69_promoter_p_PM_14_51_5			1	0.2	5.46E-05	ACVR1B, PPP2R5A, IREB2, CNOT6	positive regulation of trophoblast cell migration [BP], positive regulation of ligand-dependent nuclear receptor transcription coactivator activity [BP], development of primary female sexual characteristics [BP], negative regulation of lipid kinase activity [BP], erythrocyte homeostasis [BP]
CG_ffipsc69_promoter_p_PM_14_8_5			1	0.2	1.84E-05	PNLIPRP2, RET, MCTP2, MYL5	galactolipase activity [MF], calcium ion binding [MF]
CG_ffipsc69_promoter_p_PM_18_20_51			3	0.6	4.43E-05	CTPS1	CTP synthase activity [MF]
CG_ffipsc69_promoter_p_PM_12_53_8			2	0.4	5.79E-05	MAN1C1, ST8SIA2, CRTAP, LHX9	peptidyl-proline hydroxylation to 3-hydroxy-L-proline [BP], gonad morphogenesis [BP], integral to Golgi membrane [CC], protein N-linked glycosylation [BP], protein N-linked glycosylation via asparagine [BP]
CG_ffipsc69_promoter_p_PM_12_68_9			2	0.4	1.76E-05	MATN2	dendrite regeneration [BP]
CG_ffipsc69_promoter_p_PM_12_80_5			3	0.6	4.13E-05	CDC42	actin filament branching [BP]
CG_ffipsc69_promoter_p_PM_16_46_18			4	0.8	2.29E-05	GABARAPL1	cytoplasmic vesicle membrane [CC]
CG_ffipsc69_promoter_p_PM_16_3_9			3	0.6	4.58E-05	SLC3A2	leucine import [BP], tryptophan transport [BP]
CG_ffipsc69_promoter_p_PM_12_324_10			2	0.4	1.07E-04	SPO11, C2orf40, BRCA2	cellular senescence [BP], cell aging [BP], male meiosis I [BP]
CG_ffipsc69_promoter_p_PM_12_268_6			2	0.4	8.57E-05	STAG3, GHR, CSF2, PRMT7, LNPEP	[myelin basic protein]-arginine N-methyltransferase activity [MF], protein-arginine omega-N symmetric methyltransferase activity [MF], growth hormone receptor activity [MF], transverse filament [CC], early endosome lumen [CC], positive regulation of tyrosine phosphorylation of Stat5 protein [BP], growth hormone receptor complex [CC], granulocyte macrophage colony-stimulating factor receptor binding [MF]
CG_ffipsc69_promoter_p_PM_12_155_6			2	0.4	2.83E-05	AGXT, GNPAT, RHOQ	oxalic acid secretion [BP], glycerone-phosphate O-acyltransferase activity [MF], GBD domain binding [MF], serine-pyruvate transaminase activity [MF], peroxisomal matrix [CC]
CG_ffipsc69_promoter_p_PM_12_149_7			1	0.2	4.00E-04	AADACL4, CEL, STUB1	positive regulation of chaperone-mediated protein complex assembly [BP], protein esterification [BP], ubiquitin-dependent SMAD protein catabolic process [BP], intestinal lipid catabolic process [BP], cellular response to misfolded protein [BP], carboxylesterase activity [MF], sterol esterase activity [MF]
CG_ffipsc69_promoter_p_PM_18_31_31			4	0.8	1.12E-04	TCTN1	somatic motor neuron differentiation [BP]
CG_ffipsc69_promoter_p_PM_12_114_9			1	0.2	4.52E-05	INHBB, CRYAA, GIMAP5	positive regulation of ovulation [BP], positive regulation of natural killer cell cytokine production [BP], positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation [BP], host cell surface receptor binding [MF], M phase specific microtubule process [BP], negative regulation of hepatocyte growth factor biosynthetic process [BP]
CG_ffipsc69_promoter_p_PM_12_1_18			5	1.0	1.36E-04	PRKCD	positive regulation of sphingomyelin catabolic process [BP], negative regulation of filopodium assembly [BP], positive regulation of phospholipid scramblase activity [BP], positive regulation of glucosylceramide catabolic process [BP]
CG_ffipsc69_promoter_p_PM_16_24_17			3	0.6	5.27E-05	CFTR, FUT8, PPIF	N-glycan fucosylation [BP], channel-conductance-controlling ATPase activity [MF], glycoprotein 6-alpha-L-fucosyltransferase activity [MF], ATP-binding and phosphorylation-dependent chloride channel activity [MF], chloride channel inhibitor activity [MF], respiratory gaseous exchange [BP], regulation of proton-transporting ATPase activity, rotational mechanism [BP]
CG_ffipsc69_promoter_p_PM_12_89_5			1	0.2	2.27E-04	F2, REG3G	positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway [BP], acute-phase response [BP]
CG_ffipsc69_promoter_p_PM_12_124_14			2	0.4	5.06E-05	NTF3	regulation of synaptic transmission [BP]
CG_ffipsc69_promoter_p_PM_16_44_5			1	0.2	1.09E-04	RAD51, GZMA	negative regulation of endodeoxyribonuclease activity [BP], positive regulation of DNA ligation [BP]
CG_ffipsc69_promoter_p_PM_12_358_5			2	0.4	2.12E-04	BCL3	Bcl3-Bcl10 complex [CC]
CG_ffipsc69_promoter_p_PM_14_55_19			4	0.8	2.22E-05	AMHR2, POFUT1, NLRP2	Pyrin domain binding [MF], peptide-O-fucosyltransferase activity [MF], transforming growth factor beta receptor activity, type II [MF], protein O-linked fucosylation [BP]
CG_ffipsc69_promoter_p_PM_12_275_10			2	0.4	5.58E-05	NCKAP1L, MADD	positive regulation of CD8-positive, alpha-beta T cell differentiation [BP], negative regulation of myosin-light-chain-phosphatase activity [BP], actin polymerization-dependent cell motility [BP], SCAR complex [CC], protein kinase activator activity [MF]
CG_ffipsc69_promoter_p_PM_16_42_7			2	0.4	5.45E-05	DDX3X, CASP8, CASP8AP2	extrinsic apoptotic signaling pathway [BP], extrinsic apoptotic signaling pathway via death domain receptors [BP], positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [BP]
CG_ffipsc69_promoter_p_PM_18_28_18			1	0.2	4.68E-05	PAFAH1B1, CRCP	DNA polymerase III complex [CC], astral microtubule [CC]
CG_ffipsc69_promoter_p_PM_12_23_10			3	0.6	2.35E-04	EGR1, PDP1	[pyruvate dehydrogenase (lipoamide)] phosphatase activity [MF], response to carbon monoxide [BP], response to norepinephrine stimulus [BP], positive regulation of glomerular metanephric mesangial cell proliferation [BP], cellular response to mycophenolic acid [BP], cellular response to isoquinoline alkaloid [BP]
CG_ffipsc69_promoter_p_PM_12_207_8			2	0.4	1.18E-04	CACNA1E, HSD3B7	cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity [MF], regulation of somatostatin secretion [BP]
CG_ffipsc69_promoter_p_PM_14_45_6			1	0.2	7.22E-04	ZNF304, ZNF233, ZNF225, ZNF222	DNA binding [MF], zinc ion binding [MF]
CG_ffipsc69_promoter_p_PM_12_58_12			3	0.6	3.84E-05	KDM1A, MAPK8IP3, PKN1	activation of JUN kinase activity [BP], androgen receptor binding [MF], ligand-dependent nuclear receptor transcription coactivator activity [MF]
CG_ffipsc69_promoter_p_PM_12_246_9			5	0.8	7.01E-05	RPS15, PRMT7	ribosomal small subunit export from nucleus [BP], [myelin basic protein]-arginine N-methyltransferase activity [MF], protein-arginine omega-N symmetric methyltransferase activity [MF], peptidyl-arginine methylation, to symmetrical-dimethyl arginine [BP]
CG_ffipsc69_promoter_p_PM_14_24_15			12	1.0	4.95E-05	SENP6	SUMO-specific protease activity [MF], regulation of spindle assembly [BP], protein desumoylation [BP], regulation of kinetochore assembly [BP]
CG_ffipsc69_promoter_p_PM_16_13_12			1	0.2	3.38E-05	CPSF2, PIP5K1A	mRNA cleavage and polyadenylation specificity factor complex [CC]
CG_ffipsc69_promoter_p_PM_16_6_20			6	1.0	5.93E-05	CCDC64	Golgi to secretory granule transport [BP]
CG_ffipsc69_promoter_p_PM_12_178_11			1	0.2	1.61E-04	GNA15, ADRBK1, HSD3B7	G-protein coupled acetylcholine receptor signaling pathway [BP], activation of phospholipase C activity [BP], negative regulation of the force of heart contraction by chemical signal [BP], cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity [MF]
CG_ffipsc69_promoter_p_PM_12_104_13			1	0.2	1.98E-04	CNDP1	tripeptidase activity [MF]
CG_ffipsc69_promoter_p_PM_12_213_8			1	0.2	3.33E-05	CHIA, APLP1	cellular response to norepinephrine stimulus [BP], cell wall chitin metabolic process [BP], alpha-2B adrenergic receptor binding [MF]
CG_ffipsc69_promoter_p_PM_12_31_10			2	0.4	8.54E-05	GGPS1	farnesyltranstransferase activity [MF], geranylgeranyl diphosphate biosynthetic process [BP], geranyl diphosphate biosynthetic process [BP], geranyltranstransferase activity [MF], dimethylallyltranstransferase activity [MF], farnesyl diphosphate biosynthetic process [BP]
CG_ffipsc69_promoter_p_PM_12_36_10			2	0.4	3.21E-05	AGPS	alkylglycerone-phosphate synthase activity [MF]
CG_ffipsc69_promoter_p_PM_12_341_5			2	0.4	1.13E-04	CALCB, KNG1, PLCE1, NFATC3, F2R	muscle cell development [BP], protein kinase C-activating G-protein coupled receptor signaling pathway [BP], smooth muscle contraction [BP], cellular calcium ion homeostasis [BP], elevation of cytosolic calcium ion concentration [BP]
CG_ffipsc69_promoter_p_PM_12_197_8			2	0.4	1.18E-04	ALDH5A1, PPCDC	succinate-semialdehyde dehydrogenase (NAD+) activity [MF], phosphopantothenoylcysteine decarboxylase activity [MF], succinate-semialdehyde dehydrogenase [NAD(P)+] activity [MF]
CG_ffipsc69_promoter_p_PM_14_78_14			2	0.4	9.16E-05	RAE1, AXL, IRAK3	dendritic cell differentiation [BP], cytokine-mediated signaling pathway [BP], negative regulation of toll-like receptor signaling pathway [BP], negative regulation of tumor necrosis factor production [BP], negative regulation of cytokine-mediated signaling pathway [BP]
CG_ffipsc69_promoter_p_PM_12_67_4			1	0.2	2.09E-04	MED25	positive regulation of chromatin binding [BP], positive regulation of mediator complex assembly [BP]
CG_ffipsc69_promoter_p_PM_18_27_46			4	0.8	6.71E-05	FUS, FABP6, MAP2K7, DCLRE1B, POLI, SEPT2, DGCR8, UBAP1, CLEC3B, GTF2I, MTA1, FLYWCH1, SP1, NBPF15, MERTK, EPS8L2, SERPINB5, UBE4B, DAZAP2, RWDD3, LLGL1, ABI2, SULT2B1, C9orf3, AGBL5	intracellular [CC], cytoplasm [CC]
CG_ffipsc69_promoter_p_PM_12_265_10			3	0.6	2.23E-04	AMD1	S-adenosylmethioninamine biosynthetic process [BP], spermine biosynthetic process [BP], adenosylmethionine decarboxylase activity [MF]
CG_ffipsc69_promoter_p_PM_12_18_9			2	0.4	1.06E-05	BMP2, PTK7, PHACTR4	protein phosphatase type 1 activator activity [MF], phosphatase activator activity [MF], neural tube closure [BP], positive regulation of Wnt receptor signaling pathway by BMP signaling pathway [BP], negative regulation of integrin-mediated signaling pathway [BP], mesenchyme development [BP]
CG_ffipsc69_promoter_p_PM_14_14_21			4	0.6	1.01E-05	KHK, DNMT3B	ketohexokinase activity [MF], DNA methylation [BP]
CG_ffipsc69_promoter_p_PM_14_40_13			5	1.0	3.64E-05	RAMP2	basement membrane assembly [BP]
CG_ffipsc69_promoter_p_PM_12_100_6			1	0.2	3.20E-05	PTP4A3, CAPN3	cellular response to salt stress [BP], positive regulation of satellite cell activation involved in skeletal muscle regeneration [BP], autolysis [BP], self proteolysis [BP], prenylated protein tyrosine phosphatase activity [MF], G1 to G0 transition involved in cell differentiation [BP], negative regulation of protein sumoylation [BP]
CG_ffipsc69_promoter_p_PM_12_125_10			3	0.6	6.52E-05	AKAP13, EGFLAM	regulation of glucocorticoid mediated signaling pathway [BP], positive regulation of cell-substrate adhesion [BP]
CG_ffipsc69_promoter_p_PM_14_22_6			1	0.2	1.60E-05	KHDRBS1, RAN	Grb2-Sos complex [CC], RNA export from nucleus [BP], positive regulation of RNA export from nucleus [BP]
CG_ffipsc69_promoter_p_PM_18_5_16			4	0.8	2.90E-05	ATP1A2, GTF2I	reduction of cytosolic calcium ion concentration [BP]
CG_ffipsc69_promoter_p_PM_12_112_4			2	0.4	1.12E-05	ARID5B, SOX8	male gonad development [BP], adipose tissue development [BP], retinal rod cell differentiation [BP]
CG_ffipsc69_promoter_p_PM_12_65_5			2	0.4	8.15E-05	KIAA1279, MAPK8IP1	kinesin binding [MF]
CG_ffipsc69_promoter_p_PM_12_362_15			3	0.4	1.43E-04	ATIC	dihydrofolate metabolic process [BP], phosphoribosylaminoimidazolecarboxamide formyltransferase activity [MF], IMP cyclohydrolase activity [MF]
CG_ffipsc69_promoter_p_PM_12_77_11			3	0.6	7.47E-05	ITCH, IKBKB	nucleotide-binding oligomerization domain containing signaling pathway [BP], nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [BP]
CG_ffipsc69_promoter_p_PM_12_129_7			3	0.6	2.36E-04	PNPO	pyridoxamine-phosphate oxidase activity [MF]
CG_ffipsc69_promoter_p_PM_12_190_11			3	0.6	1.96E-05	ACACB	acetyl-CoA carboxylase activity [MF], malonyl-CoA biosynthetic process [BP]
CG_ffipsc69_promoter_p_PM_12_10_12			2	0.4	7.53E-05	KHK	ketohexokinase activity [MF]
CG_ffipsc69_promoter_p_PM_12_105_7			2	0.4	8.56E-05	PDP2, INF2, JAM3, RHOB	magnesium-dependent protein serine/threonine phosphatase activity [MF], angiogenesis [BP], regulation of actin cytoskeleton organization by cell-cell adhesion [BP], Rho GTPase binding [MF]
CG_ffipsc69_promoter_p_PM_16_57_103			6	1.0	7.68E-05	ACSS3, ACSS2, CALCOCO2, CDK9, GLS, CPS1, THRAP3	acetate-CoA ligase activity [MF], glutamine catabolic process [BP], intracellular membrane-bounded organelle [CC]
CG_ffipsc69_promoter_p_PM_18_36_29			4	0.8	4.44E-05	SIRT1, SCOC, RAC1, POLD1	cerebral cortex radially oriented cell migration [BP], cellular response to tumor necrosis factor [BP], DNA synthesis involved in DNA repair [BP], positive regulation of macroautophagy [BP]
CG_ffipsc69_promoter_p_PM_12_334_17			2	0.4	1.59E-05	SPTBN1, TAS1R3	sweet taste receptor activity [MF], detection of chemical stimulus involved in sensory perception of sweet taste [BP], membrane assembly [BP]
CG_ffipsc69_promoter_p_PM_12_242_10			3	0.6	1.44E-04	FCGR1A, SRD5A3	IgG receptor activity [MF], polyprenol catabolic process [BP], antibody-dependent cellular cytotoxicity [BP]
CG_ffipsc69_promoter_p_PM_12_350_7			2	0.4	1.18E-04	PDZK1, OXT	positive regulation of hindgut contraction [BP], oxytocin receptor binding [MF], scavenger receptor binding [MF]
CG_ffipsc69_promoter_p_PM_12_97_5			2	0.4	8.83E-05	XRN2	5'-3' exoribonuclease activity [MF]
CG_ffipsc69_promoter_p_PM_12_103_13			2	0.4	7.27E-05	ZFPM1, PDP2	magnesium-dependent protein serine/threonine phosphatase activity [MF], negative regulation of interleukin-4 biosynthetic process [BP], negative regulation of mast cell differentiation [BP]
CG_ffipsc69_promoter_p_PM_16_30_29			4	0.8	1.11E-04	PHAX	snRNA export from nucleus [BP]
CG_ffipsc69_promoter_p_PM_16_32_24			3	0.6	8.71E-05	PAFAH1B1, HPRT1	cerebral cortex neuron differentiation [BP]
CG_ffipsc69_promoter_p_PM_12_330_6			1	0.2	1.07E-04	CASQ1	terminal cisterna lumen [CC]
CG_ffipsc69_promoter_p_PM_12_106_8			2	0.4	1.12E-04	CANX, CNP, ACADS	butyrate catabolic process [BP], butyryl-CoA dehydrogenase activity [MF], 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity [MF], melanosome [CC]
CG_ffipsc69_promoter_p_PM_12_279_10			7	0.8	4.62E-05	NUDT2	bis(5'-nucleosyl)-tetraphosphatase (symmetrical) activity [MF], bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [MF]
CG_ffipsc69_promoter_p_PM_18_29_35			4	0.8	6.05E-05	RAB8B, CDH1	adherens junction organization [BP]
CG_ffipsc69_promoter_p_PM_12_303_10			3	0.6	9.28E-05	SLC20A1	high affinity inorganic phosphate:sodium symporter activity [MF]
CG_ffipsc69_promoter_p_PM_14_6_21			4	0.6	3.97E-05	FAM206A, WAC	glycine cleavage complex [CC], cell cycle checkpoint [BP], histone H2B conserved C-terminal lysine ubiquitination [BP]
CG_ffipsc69_promoter_p_PM_12_256_9			2	0.4	9.42E-06	DAND5	sequestering of nodal from receptor via nodal binding [BP], negative regulation of nodal signaling pathway [BP]
CG_ffipsc69_promoter_p_PM_14_85_6			1	0.2	4.56E-05	CARKD, ATP2A2	calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential [MF], ATP-dependent NAD(P)H-hydrate dehydratase activity [MF]
CG_ffipsc69_promoter_p_PM_14_28_18			2	0.4	3.07E-05	DRD4, PRPSAP2, PLN	negative regulation of calcium ion transmembrane transporter activity [BP], negative regulation of calcium ion binding [BP], ATPase inhibitor activity [MF], olfactory learning [BP], negative regulation of catalytic activity [BP], negative regulation of calcium-transporting ATPase activity [BP], regulation of relaxation of cardiac muscle [BP], adrenergic receptor signaling pathway involved in heart process [BP], regulation of the force of heart contraction by cardiac conduction [BP], negative regulation of voltage-gated calcium channel activity [BP]
CG_ffipsc69_promoter_p_PM_18_13_22			5	0.8	4.72E-05	HCK, TGM3, ASPA, OS9	Hrd1p ubiquitin ligase complex [CC], respiratory burst after phagocytosis [BP], extrinsic to internal side of plasma membrane [CC], aspartoacylase activity [MF]
CG_ffipsc69_promoter_p_PM_12_261_14			2	0.4	2.50E-05	PAX7	satellite cell commitment [BP]
CG_ffipsc69_promoter_p_PM_12_130_8			2	0.4	1.95E-05	CHMP7	late endosome to vacuole transport [BP]
CG_ffipsc69_promoter_p_PM_12_64_12			2	0.4	2.82E-04	CX3CL1	positive regulation of calcium-independent cell-cell adhesion [BP]
CG_ffipsc69_promoter_p_PM_12_90_10			2	0.4	4.40E-05	LRWD1	establishment of protein localization to chromatin [BP]
CG_ffipsc69_promoter_p_PM_12_121_5			2	0.4	1.38E-04	HES3	trochlear nerve development [BP]
CG_ffipsc69_promoter_p_PM_18_12_20			2	0.4	7.61E-05	TRIM71, ZP3, CAT, GPX3, PPIA, SQSTM1	positive regulation of type IV hypersensitivity [BP], positive regulation of antral ovarian follicle growth [BP], positive regulation of phosphatidylinositol biosynthetic process [BP], uncoating of virus [BP], positive regulation of acrosomal vesicle exocytosis [BP], cytoplasmic mRNA processing body [CC], menopause [BP], protein homotetramerization [BP], positive regulation of ovarian follicle development [BP], catalase activity [MF], hydrogen peroxide catabolic process [BP], oxidoreductase activity, acting on peroxide as acceptor [MF]
CG_ffipsc69_promoter_p_PM_14_1_18			3	0.6	4.46E-05	MATN2, ADRA1B	dendrite regeneration [BP], vasoconstriction of artery involved in baroreceptor response to lowering of systemic arterial blood pressure [BP]
CG_ffipsc69_promoter_p_PM_12_269_7			2	0.4	8.44E-05	NDEL1, DNASE1	oligopeptidase activity [MF], deoxyribonuclease I activity [MF]
CG_ffipsc69_promoter_p_PM_12_162_12			3	0.6	1.60E-04	WNT9B	establishment of planar polarity involved in nephron morphogenesis [BP], mesonephric duct formation [BP]
CG_ffipsc69_promoter_p_PM_12_88_8			2	0.4	5.54E-05	CSF1, SDCBP, ROBO2	macrophage colony-stimulating factor receptor binding [MF], syndecan binding [MF], interleukin-5 receptor complex [CC], apoptotic process involved in luteolysis [BP], Ras protein signal transduction [BP], mammary gland fat development [BP], negative regulation of negative chemotaxis [BP], positive regulation of odontogenesis of dentin-containing tooth [BP], interleukin-5 receptor binding [MF], identical protein binding [MF], substrate-dependent cell migration, cell extension [BP]
CG_ffipsc69_promoter_p_PM_12_37_10			2	0.4	1.32E-04	AKR1E2, MTR	1,5-anhydro-D-fructose reductase activity [MF], methionine synthase activity [MF]
CG_ffipsc69_promoter_p_PM_12_346_9			2	0.4	4.87E-05	PNRC2	deadenylation-independent decapping of nuclear-transcribed mRNA [BP]
CG_ffipsc69_promoter_p_PM_12_240_11			2	0.4	2.90E-05	UBE2A	HULC complex [CC]
CG_ffipsc69_promoter_p_PM_12_336_5			2	0.4	1.51E-04	TRAF2, IKBKB	CD40 receptor complex [CC]
CG_ffipsc69_promoter_p_PM_18_23_22			2	0.4	5.11E-05	SP5, GGPS1, TMED2	post-anal tail morphogenesis [BP], geranylgeranyl diphosphate biosynthetic process [BP]
CG_ffipsc69_promoter_p_PM_14_42_11			2	0.4	5.40E-05	ITGAM, PPOX	oxygen-dependent protoporphyrinogen oxidase activity [MF], microglia development [BP]
CG_ffipsc69_promoter_p_PM_12_361_10			2	0.4	5.89E-05	GAR1, LMTK2	box H/ACA snoRNP complex [CC], myosin VI binding [MF]
CG_ffipsc69_promoter_p_PM_12_332_6			2	0.4	1.10E-04	ATP2A1, EDDM3A	sperm displacement [BP], elevation of endoplasmic reticulum calcium ion concentration [BP], relaxation of skeletal muscle [BP], positive regulation of fast-twitch skeletal muscle fiber contraction [BP]
CG_ffipsc69_promoter_p_PM_12_6_4			1	0.2	2.86E-05	FNDC1, GRIN1	positive regulation of cardiac muscle cell apoptotic process [BP], propylene metabolic process [BP]
CG_ffipsc69_promoter_p_PM_12_96_10			1	0.2	6.75E-04	LRSAM1	ubiquitin-dependent endocytosis [BP], non-lytic virus budding [BP]
CG_ffipsc69_promoter_p_PM_12_71_11			1	0.2	1.46E-04	CLIC4, KATNB1, IL6	interleukin-6 receptor complex [CC], hepatic immune response [BP], response to calcium ion [BP], midbody [CC], katanin complex [CC], negative regulation of chemokine biosynthetic process [BP], negative regulation of collagen biosynthetic process [BP], positive regulation of STAT protein import into nucleus [BP], positive regulation of microtubule depolymerization [BP]
CG_ffipsc69_promoter_p_PM_14_27_20			3	0.6	4.11E-05	P2RX7	regulation of sodium ion transport [BP]
CG_ffipsc69_promoter_p_PM_12_326_4			1	0.2	2.00E-04	ACTN4, PDE8B	phosphorelay response regulator activity [MF], positive regulation of pinocytosis [BP]
CG_ffipsc69_promoter_p_PM_12_291_9			2	0.4	8.55E-05	MGMT	methylated-DNA-[protein]-cysteine S-methyltransferase activity [MF]
CG_ffipsc69_promoter_p_PM_14_17_12			2	0.4	1.01E-04	DRAXIN	commissural neuron differentiation in spinal cord [BP]
CG_ffipsc69_promoter_p_PM_14_56_7			4	0.8	1.86E-05	SND1, RBM4	IRES-dependent translational initiation [BP], cap-independent translational initiation [BP], gene silencing by RNA [BP], circadian regulation of translation [BP], pre-mRNA intronic pyrimidine-rich binding [MF]
CG_ffipsc69_promoter_p_PM_12_271_7			2	0.4	1.19E-04	LEP, COL3A1, MINPP1, TYR, MLPH, MYRIP	monophenol monooxygenase activity [MF], bisphosphoglycerate 3-phosphatase activity [MF], polyphosphate metabolic process [BP], inositol hexakisphosphate 2-phosphatase activity [MF], cellular response to L-ascorbic acid [BP], negative regulation of glutamine transport [BP], Rab GTPase binding [MF], collagen type III [CC]
CG_ffipsc69_promoter_p_PM_12_192_3			1	0.2	5.35E-05	PLEK, PDE1B	negative regulation of inositol phosphate biosynthetic process [BP], phospholipase C-inhibiting G-protein coupled receptor signaling pathway [BP], positive regulation of inositol-polyphosphate 5-phosphatase activity [BP], protein secretion by platelet [BP], regulation of cell diameter [BP], calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity [MF]
CG_ffipsc69_promoter_p_PM_12_139_16			4	0.8	2.90E-04	RAP1A, GNG3	energy reserve metabolic process [BP]
CG_ffipsc69_promoter_p_PM_12_81_11			2	0.4	6.26E-05	PGAM1	regulation of pentose-phosphate shunt [BP]
CG_ffipsc69_promoter_p_PM_16_23_25			4	0.8	5.08E-05	IL10RA, MUS81	3'-flap endonuclease activity [MF], interleukin-10 receptor activity [MF]
CG_ffipsc69_promoter_p_PM_12_107_7			1	0.2	8.50E-06	ANO1, CECR2	intracellular calcium activated chloride channel activity [MF], nucleosome-dependent ATPase activity [MF]
CG_ffipsc69_promoter_p_PM_12_234_9			3	0.6	1.24E-04	KAT2B, NCOA1	positive regulation of transcription from RNA polymerase II promoter by galactose [BP], histone acetyltransferase activity [MF]
CG_ffipsc69_promoter_p_PM_12_28_11			2	0.4	1.12E-04	LTB4R	leukotriene B4 receptor activity [MF]
CG_ffipsc69_promoter_p_PM_12_340_7			1	0.2	1.33E-04	SORD	sorbitol catabolic process [BP], L-iditol 2-dehydrogenase activity [MF], fructose biosynthetic process [BP], L-xylitol catabolic process [BP], L-xylitol metabolic process [BP]
CG_ffipsc69_promoter_p_PM_14_58_6			1	0.2	4.23E-05	MED25	positive regulation of chromatin binding [BP], positive regulation of mediator complex assembly [BP]
CG_ffipsc69_promoter_p_PM_12_272_14			4	0.8	7.31E-05	BCO2	carotenoid metabolic process [BP], carotene catabolic process [BP], carotene metabolic process [BP]
CG_ffipsc69_promoter_p_PM_14_65_13			3	0.6	5.14E-05	MAP3K1, TUBB, RAC1, MAST1	cytoskeleton organization [BP], positive regulation of actin filament polymerization [BP], protein polymerization [BP]
CG_ffipsc69_promoter_p_PM_16_35_25			5	0.8	4.51E-05	DNM1L, LARS2, IGF2BP1	membrane fission involved in mitochondrial fission [BP], leucyl-tRNA aminoacylation [BP], leucine-tRNA ligase activity [MF], regulation of mRNA stability involved in response to stress [BP], regulation of peroxisome organization [BP], dynamin polymerization involved in mitochondrial fission [BP]
CG_ffipsc69_promoter_p_PM_18_9_17			4	0.8	4.87E-05	TADA2A, CCDC101	Ada2/Gcn5/Ada3 transcription activator complex [CC]
CG_ffipsc69_promoter_p_PM_12_79_9			4	0.6	2.38E-04	SLC22A5	sodium-dependent organic cation transport [BP], positive regulation of intestinal epithelial structure maintenance [BP], quorum sensing involved in interaction with host [BP]
CG_ffipsc69_promoter_p_PM_14_43_9			3	0.6	3.06E-05	ACOT4, RAB7A	epidermal growth factor catabolic process [BP], unsaturated monocarboxylic acid metabolic process [BP], saturated monocarboxylic acid metabolic process [BP], succinyl-CoA hydrolase activity [MF]
CG_ffipsc69_promoter_p_PM_12_17_6			2	0.4	3.98E-05	PDPK1	3-phosphoinositide-dependent protein kinase activity [MF]
CG_ffipsc69_promoter_p_PM_12_319_6			3	0.6	1.17E-04	FN3K	fructosamine-3-kinase activity [MF], fructoselysine metabolic process [BP]
CG_ffipsc69_promoter_p_PM_12_273_5			4	0.6	1.68E-04	ZNF205, SERPINE1, ATP6V0A2, DYNLL2, VEZT	negative regulation of vascular wound healing [BP], synaptic target recognition [BP], positive regulation of leukotriene production involved in inflammatory response [BP], positive regulation of mitochondrial outer membrane permeabilization [BP], acrosomal vesicle [CC], positive regulation of hydrogen peroxide biosynthetic process [BP]
CG_ffipsc69_promoter_p_PM_16_25_30			2	0.4	9.55E-05	KATNB1	katanin complex [CC]
CG_ffipsc69_promoter_p_PM_12_317_4			2	0.4	1.66E-04	REEP2	taste receptor binding [MF]
CG_ffipsc69_promoter_p_PM_12_41_8			2	0.4	6.50E-05	CDH15, VLDLR, CDH13	calcium ion binding [MF], reelin receptor activity [MF], reelin-mediated signaling pathway [BP], lipoprotein particle binding [MF], low-density lipoprotein particle mediated signaling [BP], glycoprotein transport [BP], adiponectin binding [MF], homophilic cell adhesion [BP], cell-cell junction organization [BP], caveola [CC], adherens junction organization [BP], very-low-density lipoprotein particle receptor activity [MF], cell junction assembly [BP], very-low-density lipoprotein particle binding [MF], glycoprotein transporter activity [MF]
CG_ffipsc69_promoter_p_PM_12_333_10			2	0.4	6.12E-05	ATP2C1, EXO1, NUDT2, AGBL5	manganese-transporting ATPase activity [MF], cellular manganese ion homeostasis [BP], Golgi calcium ion homeostasis [BP], protein branching point deglutamylation [BP], bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [MF], double-stranded DNA specific 5'-3' exodeoxyribonuclease activity [MF], bis(5'-nucleosyl)-tetraphosphatase (symmetrical) activity [MF], Golgi calcium ion transport [BP]
CG_ffipsc69_promoter_p_PM_14_16_5			2	0.4	8.92E-05	PDIA3, ATP6V0A1, BSG	melanosome [CC]
CG_ffipsc69_promoter_p_PM_12_9_7			2	0.4	2.06E-04	SQLE	squalene monooxygenase activity [MF]
CG_ffipsc69_promoter_p_PM_12_293_9			3	0.6	9.58E-05	PCDHGA9, PCDHGA6, PCDHGA8	homophilic cell adhesion [BP]
CG_ffipsc69_promoter_p_PM_14_23_16			12	1.0	5.13E-05	GADD45B, TAB1	activation of MAPKKK activity [BP]
CG_ffipsc69_promoter_p_PM_12_46_12			3	0.4	1.99E-04	TPST1, NUDT1	8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity [MF], DNA protection [BP], dGTP catabolic process [BP], ATP diphosphatase activity [MF], 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity [MF], protein-tyrosine sulfotransferase activity [MF], peptidyl-tyrosine sulfation [BP]
CG_ffipsc69_promoter_p_PM_12_348_11			1	0.2	1.11E-05	BICD1	tubulin complex [CC], negative regulation of phospholipase C activity [BP], host cell viral assembly compartment [CC], proteinase activated receptor binding [MF], negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway [BP], regulation of proteinase activated receptor activity [BP]
CG_ffipsc69_promoter_p_PM_12_245_8			2	0.4	1.18E-04	THBS1, AP1AR	negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II [BP], negative regulation of cGMP-mediated signaling [BP], negative regulation of nitric oxide mediated signal transduction [BP], regulation of Arp2/3 complex-mediated actin nucleation [BP], positive regulation of eukaryotic cell surface binding [BP], negative regulation of dendritic cell antigen processing and presentation [BP]
CG_ffipsc69_promoter_p_PM_18_6_26			4	0.8	2.85E-05	BIRC2, TRAF2	CD40 receptor complex [CC]
CG_ffipsc69_promoter_p_PM_12_367_10			2	0.4	1.62E-04	ZP3	positive regulation of type IV hypersensitivity [BP], positive regulation of acrosomal vesicle exocytosis [BP], positive regulation of antral ovarian follicle growth [BP], positive regulation of phosphatidylinositol biosynthetic process [BP], positive regulation of ovarian follicle development [BP]
CG_ffipsc69_promoter_p_PM_16_54_11			3	0.6	8.07E-05	EHD2, CABP1, PRDX5	regulation of apoptosis involved in tissue homeostasis [BP], peroxynitrite reductase activity [MF], perinuclear region of cytoplasm [CC], negative regulation of transcription from RNA polymerase III promoter [BP]
CG_ffipsc69_promoter_p_PM_12_15_9			3	0.6	2.62E-05	SLC12A5	thermosensory behavior [BP]
CG_ffipsc69_promoter_p_PM_12_29_7			2	0.4	9.53E-05	SGIP1	positive regulation of feeding behavior [BP]
CG_ffipsc69_promoter_p_PM_12_342_13			2	0.4	2.91E-04	PDZD3, NAA60, CDH13	subapical complex [CC], negative regulation of cGMP biosynthetic process [BP], adiponectin binding [MF], negative regulation of guanylate cyclase activity [BP], guanylate cyclase inhibitor activity [MF], N-terminal peptidyl-methionine acetylation [BP]
CG_ffipsc69_promoter_p_PM_12_228_7			1	0.2	1.55E-04	GNAS, ADSSL1	adenylosuccinate synthase activity [MF], post-embryonic body morphogenesis [BP], mu-type opioid receptor binding [MF]
CG_ffipsc69_promoter_p_PM_12_214_13			4	0.8	6.24E-05	USP9Y, CACNA1G, ZNF639	positive regulation of cell growth [BP], response to nickel cation [BP], BMP signaling pathway [BP]
CG_ffipsc69_promoter_p_PM_12_108_9			2	0.4	2.40E-05	PRKCE, PNPO, ECT2, SLC2A4	TRAM-dependent toll-like receptor 4 signaling pathway [BP], positive regulation of cell cycle cytokinesis [BP], ethanol binding [MF], amylopectin biosynthetic process [BP], pyridoxamine-phosphate oxidase activity [MF], positive regulation of cellular glucuronidation [BP], cell cycle cytokinesis [BP]
CG_ffipsc69_promoter_p_PM_12_160_11			1	0.2	1.51E-04	BBS4, ZRANB1	protein deubiquitination involved in ubiquitin-dependent protein catabolic process [BP], positive regulation of flagellum assembly [BP]
CG_ffipsc69_promoter_p_PM_12_86_5			1	0.2	1.95E-04	MSRA	peptide-methionine (S)-S-oxide reductase activity [MF]
CG_ffipsc69_promoter_p_PM_18_19_21			4	0.8	3.24E-05	ADK	dATP biosynthetic process [BP]
CG_ffipsc69_promoter_p_PM_16_19_13			4	0.8	4.86E-05	GPX4, G6PC	glucose-6-phosphatase activity [MF], phospholipid-hydroperoxide glutathione peroxidase activity [MF]
CG_ffipsc69_promoter_p_PM_12_75_8			2	0.4	4.96E-05	PHGDH, URI1, SPRED1	phosphoglycerate dehydrogenase activity [MF], negative regulation of phosphatase activity [BP]
CG_ffipsc69_promoter_p_PM_12_87_10			2	0.4	1.40E-04	OPRD1	enkephalin receptor activity [MF]
CG_ffipsc69_promoter_p_PM_14_60_12			3	0.6	3.28E-05	PIN1, PVRL2, ATRAID, RAB8A	sperm mitochondrion organization [BP], phosphothreonine binding [MF], virion attachment, binding of host cell surface coreceptor [BP], Golgi vesicle fusion to target membrane [BP], negative regulation of cyclin catabolic process [BP], susceptibility to T cell mediated cytotoxicity [BP]
CG_ffipsc69_promoter_p_PM_12_366_9			2	0.4	7.34E-05	SPCS3, GNAT1	acyl binding [MF], negative regulation of cyclic-nucleotide phosphodiesterase activity [BP], signal peptidase complex [CC], positive regulation of cyclic-nucleotide phosphodiesterase activity [BP]
CG_ffipsc69_promoter_p_PM_12_12_9			2	0.4	1.62E-04	ERLIN2, FBXO6, ASRGL1	asparagine catabolic process via L-aspartate [BP], ER-associated protein catabolic process [BP]
CG_ffipsc69_promoter_p_PM_12_281_19			7	0.8	1.28E-04	PTOV1, CDC20, SCN2A, EIF4H, MAG, BICD1, USP20, CYFIP1	paranode region of axon [CC], perinuclear region of cytoplasm [CC]
CG_ffipsc69_promoter_p_PM_16_14_22			1	0.2	2.43E-05	DLD, ST3GAL6	dihydrolipoyl dehydrogenase activity [MF], beta-galactoside alpha-2,3-sialyltransferase activity [MF]
CG_ffipsc69_promoter_p_PM_12_95_4			3	0.6	2.69E-05	BMPR2, TGM4, IFNL1	negative regulation of memory T cell differentiation [BP], interleukin-28 receptor binding [MF], vascular endothelial growth factor receptor signaling pathway [BP], protein polyamination [BP]
CG_ffipsc69_promoter_p_PM_14_52_5			2	0.4	1.28E-04	GSTO1	positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [BP]
CG_ffipsc69_promoter_p_PM_12_110_8			1	0.2	1.54E-04	GNAS, CSF1	positive regulation of osteoclast differentiation [BP]
CG_ffipsc69_promoter_p_PM_12_360_6			3	0.6	1.38E-05	PPARA, IL1R1	regulation of glycolysis by positive regulation of transcription from RNA polymerase II promoter [BP], interleukin-1, Type I, activating receptor activity [MF], regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter [BP], regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter [BP]
CG_ffipsc69_promoter_p_PM_12_305_8			2	0.4	1.01E-04	PVRL2	virion attachment, binding of host cell surface coreceptor [BP]
CG_ffipsc69_promoter_p_PM_16_34_15			2	0.4	1.82E-05	EIF3L, PSEN2	myeloid leukocyte differentiation [BP], fibrillar center [CC]
CG_ffipsc69_promoter_p_PM_12_220_5			3	0.6	1.05E-04	MPST, KANK1, PARK7	positive regulation of oxidative phosphorylation uncoupler activity [BP], 3-mercaptopyruvate sulfurtransferase activity [MF], negative regulation of lamellipodium morphogenesis [BP]
CG_ffipsc69_promoter_p_PM_16_21_11			1	0.2	9.95E-05	DAO, TFAP2B	D-alanine catabolic process [BP], D-serine catabolic process [BP], cellular urea homeostasis [BP], D-amino-acid oxidase activity [MF], cellular creatinine homeostasis [BP], magnesium ion homeostasis [BP], ductus arteriosus closure [BP], D-serine metabolic process [BP], cellular ammonia homeostasis [BP]
CG_ffipsc69_promoter_p_PM_12_339_7			1	0.2	5.25E-05	PRMT7, KLC2	[myelin basic protein]-arginine N-methyltransferase activity [MF], kinesin I complex [CC]
CG_ffipsc69_promoter_p_PM_12_199_9			4	0.8	3.71E-04	KIF19	plus-end specific microtubule depolymerization [BP], axonemal microtubule depolymerization [BP]
CG_ffipsc69_promoter_p_PM_12_253_7			2	0.4	6.14E-05	HSD17B2	testosterone 17-beta-dehydrogenase (NAD+) activity [MF], 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity [MF]
CG_ffipsc69_promoter_p_PM_12_294_9			3	0.6	4.53E-05	GM2A	sphingolipid activator protein activity [MF]
CG_ffipsc69_promoter_p_PM_14_71_7			2	0.4	2.54E-05	SLC50A1, INPP5D	glucoside transport [BP], glucoside transmembrane transporter activity [MF], negative regulation of neutrophil differentiation [BP]
CG_ffipsc69_promoter_p_PM_14_31_27			4	0.6	1.08E-04	HTR3B, EPB41, TRAF2	serotonin-activated cation-selective channel activity [MF], positive regulation of protein binding [BP], CD40 receptor binding [MF]
CG_ffipsc69_promoter_p_PM_12_48_8			2	0.4	1.16E-04	ENOPH1, PCK1, UROD	acireductone synthase activity [MF], uroporphyrinogen decarboxylase activity [MF], glycerol biosynthetic process from pyruvate [BP]
CG_ffipsc69_promoter_p_PM_12_224_6			2	0.4	2.81E-04	TSC2	positive chemotaxis [BP]
CG_ffipsc69_promoter_p_PM_16_58_76			5	1.0	5.77E-05	WDTC1, EGR1, CHRM3, PTCD3, MAP2K1, DENND4C, DDX25	cellular response to insulin stimulus [BP], regulation of vascular smooth muscle contraction [BP], regulation of translation [BP]
CG_ffipsc69_promoter_p_PM_12_226_5			1	0.2	2.09E-04	PDIA5, TATDN2, RANBP2, DNAJC5	protein folding [BP], activation of signaling protein activity involved in unfolded protein response [BP]
CG_ffipsc69_promoter_p_PM_12_5_7			2	0.4	7.63E-06	MYLIP	regulation of low-density lipoprotein particle receptor catabolic process [BP], negative regulation of low-density lipoprotein particle clearance [BP]
CG_ffipsc69_promoter_p_PM_14_77_5			2	0.4	1.91E-05	PPP1CB	myosin phosphatase activity [MF], myosin-light-chain-phosphatase activity [MF]
CG_ffipsc69_promoter_p_PM_12_331_12			2	0.4	1.23E-04	PTGS1, DNAAF1	prostaglandin-endoperoxide synthase activity [MF], motile cilium assembly [BP], inner dynein arm assembly [BP], regulation of cilium beat frequency [BP], cyclooxygenase pathway [BP], outer dynein arm assembly [BP]
CG_ffipsc69_promoter_p_PM_12_298_7			3	0.6	1.65E-04	TDP1, DOLPP1	3'-tyrosyl-DNA phosphodiesterase activity [MF], dolichyldiphosphatase activity [MF]
CG_ffipsc69_promoter_p_PM_16_31_33			4	0.8	1.67E-05	CTPS1	CTP synthase activity [MF], 'de novo' CTP biosynthetic process [BP]
CG_ffipsc69_promoter_p_PM_12_141_4			2	0.4	8.92E-05	INSIG1, OPRM1	morphine receptor activity [MF], beta-endorphin receptor activity [MF], negative regulation of cargo loading into COPII-coated vesicle [BP], negative regulation of Wnt protein secretion [BP]
CG_ffipsc69_promoter_p_PM_14_36_11			4	0.8	6.80E-05	UGT1A9, SCPEP1	retinoic acid metabolic process [BP]
CG_ffipsc69_promoter_p_PM_12_309_8			2	0.4	1.83E-04	DRAXIN, GRM2	commissural neuron differentiation in spinal cord [BP], group II metabotropic glutamate receptor activity [MF]
CG_ffipsc69_promoter_p_PM_12_263_10			1	0.2	3.46E-05	KIF26B	ureteric bud invasion [BP]
CG_ffipsc69_promoter_p_PM_16_27_12			4	0.8	5.81E-06	CEP95	spindle pole [CC]
CG_ffipsc69_promoter_p_PM_12_4_15			2	0.4	9.83E-05	CAPN10, CAPN3	calcium-dependent cysteine-type endopeptidase activity [MF]
CG_ffipsc69_promoter_p_PM_12_132_10			3	0.6	5.46E-05	VIL1, CHMP7, AIP, TPCN2, MOCOS	cytoplasmic actin-based contraction involved in cell motility [BP], GAF domain binding [MF], lysophosphatidic acid binding [MF], Mo-molybdopterin cofactor sulfurase activity [MF], late endosome to vacuole transport [BP], endosome membrane [CC]
CG_ffipsc69_promoter_p_PM_14_57_15			4	0.8	3.69E-05	NUDT2, YWHAH, DAG1, SQRDL, CREBRF	nerve maturation [BP], sulfide:quinone oxidoreductase activity [MF], bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [MF], bis(5'-nucleosyl)-tetraphosphatase (symmetrical) activity [MF], negative regulation of endoplasmic reticulum unfolded protein response [BP], glucocorticoid catabolic process [BP]
CG_ffipsc69_promoter_p_PM_16_50_11			5	0.8	4.15E-05	SPINK5	regulation of cell adhesion [BP]
CG_ffipsc69_promoter_p_PM_12_359_9			2	0.4	2.23E-04	ACE, FKBP1B	negative regulation of release of sequestered calcium ion into cytosol [BP], positive regulation of sequestering of calcium ion [BP], drug binding [MF], peptidyl-dipeptidase activity [MF], bradykinin receptor binding [MF]
CG_ffipsc69_promoter_p_PM_12_188_6			2	0.4	1.67E-04	HELLS, GDF15, TNFRSF11A, LRWD1, GJA8	cell-cell signaling [BP], centromeric heterochromatin [CC], circadian temperature homeostasis [BP]
CG_ffipsc69_promoter_p_PM_12_93_10			4	0.8	1.07E-04	CNDP1	tripeptidase activity [MF]
CG_ffipsc69_promoter_p_PM_14_19_11			1	0.2	7.73E-05	TBCE, RPS19, IL1R2, RPLP1	translational elongation [BP], peripheral nervous system neuron axonogenesis [BP], structural constituent of ribosome [MF], interleukin-1, Type II, blocking receptor activity [MF], nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [BP], translational termination [BP], SRP-dependent cotranslational protein targeting to membrane [BP]
CG_ffipsc69_promoter_p_PM_12_133_12			2	0.4	3.10E-05	WDYHV1	protein-N-terminal glutamine amidohydrolase activity [MF]
CG_ffipsc69_promoter_p_PM_12_44_6			2	0.4	5.37E-05	USP1, UBE2V2, ATM, FGFR4, NEK6	protein autophosphorylation [BP], G2/M transition DNA damage checkpoint [BP], regulation of mitotic metaphase/anaphase transition [BP], regulation of DNA repair [BP]
CG_ffipsc69_promoter_p_PM_16_16_11			2	0.4	1.13E-04	KATNB1, HCK	respiratory burst after phagocytosis [BP], katanin complex [CC], leukocyte migration involved in immune response [BP]
CG_ffipsc69_promoter_p_PM_12_14_11			2	0.4	1.45E-04	NMRK2, SNTG2	ribosylnicotinamide kinase activity [MF], syntrophin complex [CC]
CG_ffipsc69_promoter_p_PM_12_191_3			1	0.2	5.79E-05	ST3GAL4, APOE	metal chelating activity [MF], monosialoganglioside sialyltransferase activity [MF]
CG_ffipsc69_promoter_p_PM_12_148_10			3	0.6	1.80E-04	PVRL2	virion attachment, binding of host cell surface coreceptor [BP]
CG_ffipsc69_promoter_p_PM_12_329_6			2	0.4	4.81E-05	EIF2A	eukaryotic translation initiation factor 2 complex [CC]
CG_ffipsc69_promoter_p_PM_12_337_5			2	0.4	1.97E-05	ECT2, TRMT44, PUS1	tRNA processing [BP], tRNA pseudouridine synthesis [BP], pseudouridylate synthase activity [MF], centralspindlin complex [CC]
CG_ffipsc69_promoter_p_PM_14_88_13			1	0.2	7.22E-05	TRAPPC4, COL9A3	TRAPP complex [CC], collagen type IX [CC]
CG_ffipsc69_promoter_p_PM_12_156_10			3	0.6	1.11E-04	MAVS, NOD2, FCER1G	negative regulation of interleukin-18 production [BP], muramyl dipeptide binding [MF], positive regulation of interleukin-10 production [BP], CARD domain binding [MF], positive regulation of dendritic cell cytokine production [BP], detection of muramyl dipeptide [BP], positive regulation of IP-10 production [BP], response to exogenous dsRNA [BP], positive regulation of phagocytosis [BP], defense response to bacterium [BP], cytokine production involved in immune response [BP], positive regulation of interleukin-6 production [BP], IgE receptor activity [MF], neutrophil chemotaxis [BP], positive regulation of tumor necrosis factor production [BP], Fc-epsilon receptor I complex [CC], positive regulation of prostaglandin-E synthase activity [BP]
CG_ffipsc69_promoter_p_PM_12_83_13			2	0.4	4.30E-05	RBCK1, SP1, TGFBR2	positive regulation of tolerance induction to self antigen [BP], bronchus morphogenesis [BP], type III transforming growth factor beta receptor binding [MF], trachea formation [BP], embryonic skeletal system development [BP], transforming growth factor beta receptor activity, type II [MF], positive regulation of B cell tolerance induction [BP], protein linear polyubiquitination [BP], lung development [BP], transforming growth factor beta receptor signaling pathway [BP]
CG_ffipsc69_promoter_p_PM_12_159_10			3	0.6	2.45E-04	HS3ST3B1, F2RL3	heparan sulfate proteoglycan biosynthetic process, enzymatic modification [BP], platelet dense granule organization [BP], [heparan sulfate]-glucosamine 3-sulfotransferase 3 activity [MF]
CG_ffipsc69_promoter_p_PM_12_345_14			2	0.4	3.70E-05	ADSSL1	adenylosuccinate synthase activity [MF], 'de novo' AMP biosynthetic process [BP]
CG_ffipsc69_promoter_p_PM_12_111_19			4	0.6	8.54E-05	ADHFE1	hydroxyacid-oxoacid transhydrogenase activity [MF]
CG_ffipsc69_promoter_p_PM_12_343_11			1	0.2	3.04E-04	DIO3, GRIN1	thyroxine 5-deiodinase activity [MF], propylene metabolic process [BP]
CG_ffipsc69_promoter_p_PM_14_37_9			3	0.6	2.25E-05	AGPAT6	glandular epithelial cell maturation [BP]
CG_ffipsc69_promoter_p_PM_14_62_5			2	0.4	1.37E-05	WFS1, MAT2A, BAG4, ME2, PCYOX1	negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [BP], chloride-transporting ATPase activity [MF], malate dehydrogenase (decarboxylating) activity [MF], negative regulation of type B pancreatic cell apoptotic process [BP], prenylcysteine oxidase activity [MF], sulfur amino acid metabolic process [BP]
CG_ffipsc69_promoter_p_PM_12_193_7			2	0.4	7.58E-05	SMTNL1, CAMK1D, CNN2	calmodulin binding [MF]
CG_ffipsc69_promoter_p_PM_12_286_12			2	0.4	5.53E-05	AP2A2	protein transporter activity [MF]
CG_ffipsc69_promoter_p_PM_18_34_32			4	0.8	5.51E-05	D2HGDH, CDC7, CA2	regulation of S phase [BP], response to zinc ion [BP]
CG_ffipsc69_promoter_p_PM_12_135_7			2	0.4	1.55E-04	FOS, AQP9, NUDT9	ADP catabolic process [BP], response to cAMP [BP], pyrimidine nucleobase transport [BP]
CG_ffipsc69_promoter_p_PM_18_22_10			1	0.2	9.26E-06	SNRPN, IL23A, CLN8, TIRAP	U2 snRNP [CC], U1 snRNP [CC], positive regulation of chemokine (C-X-C motif) ligand 1 production [BP], Toll-like receptor 4 binding [MF], age-dependent response to oxidative stress [BP], Toll-like receptor 2 binding [MF], positive regulation of neutrophil chemotaxis [BP], positive regulation of toll-like receptor 3 signaling pathway [BP], positive regulation of interleukin-15 production [BP], TIRAP-dependent toll-like receptor 4 signaling pathway [BP], interleukin-23 receptor binding [MF], L-glutamate uptake involved in synaptic transmission [BP], positive regulation of interleukin-12 production [BP], positive regulation of tumor necrosis factor production [BP], positive regulation of toll-like receptor 2 signaling pathway [BP], positive regulation of NK T cell proliferation [BP], interleukin-23 complex [CC]
CG_ffipsc69_promoter_p_PM_12_262_11			2	0.4	2.77E-04	ASS1, IL4	argininosuccinate synthase activity [MF], negative regulation of T-helper 17 cell differentiation [BP], interleukin-4 receptor binding [MF], connective tissue growth factor biosynthetic process [BP]
CG_ffipsc69_promoter_p_PM_16_9_10			1	0.2	2.82E-05	PHACTR4, DAND5, MRI1, TXNIP	sequestering of nodal from receptor via nodal binding [BP], L-methionine biosynthetic process from S-adenosylmethionine [BP], cellular response to tumor cell [BP], negative regulation of integrin-mediated signaling pathway [BP]
CG_ffipsc69_promoter_p_PM_12_297_16			3	0.6	1.11E-04	AKR1C3, MAMLD1	male gonad development [BP]
CG_ffipsc69_promoter_p_PM_12_119_12			2	0.4	4.00E-05	CDC6, KMO	positive regulation of chromosome segregation [BP], regulation of mitotic anaphase [BP], kynurenine 3-monooxygenase activity [MF]
CG_ffipsc69_promoter_p_PM_12_325_6			2	0.4	5.62E-05	C1GALT1, MLYCD	glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [MF], malonyl-CoA catabolic process [BP], malonyl-CoA decarboxylase activity [MF]
CG_ffipsc69_promoter_p_PM_12_321_10			3	0.6	1.49E-04	LHX9	gonad morphogenesis [BP]
CG_ffipsc69_promoter_p_PM_12_42_7			2	0.4	3.24E-05	HMOX2, ACSF3	malonate catabolic process [BP], heme oxygenase (decyclizing) activity [MF], heme oxidation [BP], malonyl-CoA synthetase activity [MF]
CG_ffipsc69_promoter_p_PM_12_170_11			1	0.2	9.31E-05	SF3A2, CLN5	neuron maturation [BP], small nuclear ribonucleoprotein complex [CC]
CG_ffipsc69_promoter_p_PM_12_296_11			1	0.2	2.45E-04	CSF1, NDOR1	mammary gland fat development [BP], macrophage colony-stimulating factor receptor binding [MF], cellular response to menadione [BP], positive regulation of odontogenesis of dentin-containing tooth [BP]
CG_ffipsc69_promoter_p_PM_12_24_6			2	0.4	8.27E-05	SLC38A3, MOG	asparagine transport [BP], histidine transport [BP], positive regulation of MyD88-dependent toll-like receptor signaling pathway [BP]
CG_ffipsc69_promoter_p_PM_12_131_12			2	0.4	2.06E-04	GYG2, UGT1A1	glycogenin glucosyltransferase activity [MF], digestion [BP], biphenyl catabolic process [BP], cytochrome complex [CC], bilirubin conjugation [BP]
CG_ffipsc69_promoter_p_PM_12_177_7			2	0.4	1.94E-04	GSTZ1, POLR2C, FTSJD2	maleylacetoacetate isomerase activity [MF], mRNA (nucleoside-2'-O-)-methyltransferase activity [MF], mRNA methylation [BP], 7-methylguanosine mRNA capping [BP]
CG_ffipsc69_promoter_p_PM_12_84_7			2	0.4	7.71E-06	NAA60	N-terminal peptidyl-methionine acetylation [BP]
CG_ffipsc69_promoter_p_PM_12_198_10			1	0.2	1.80E-04	LSP1, TNNI2, PHACTR3, MPRIP	actin binding [MF]
CG_ffipsc69_promoter_p_PM_12_338_7			2	0.4	1.68E-04	SPTBN1	membrane assembly [BP]
CG_ffipsc69_promoter_p_PM_12_142_7			2	0.4	2.34E-04	SUV39H2, SPDYA	male meiosis [BP]
CG_ffipsc69_promoter_p_PM_14_20_13			3	0.4	2.95E-05	MSH3, TSSK2, SAA1, CXADR	acrosomal vesicle [CC], neutrophil chemotaxis [BP], MutSbeta complex [CC], double-strand/single-strand DNA junction binding [MF], dinucleotide repeat insertion binding [MF]
CG_ffipsc69_promoter_p_PM_16_40_26			5	1.0	1.52E-05	SOX17	inner cell mass cellular morphogenesis [BP], cardiogenic plate morphogenesis [BP], regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification [BP]
CG_ffipsc69_promoter_p_PM_12_127_4			1	0.2	1.72E-04	CACNA1D, BMP15, MACF1	voltage-gated calcium channel activity involved in regulation of SA node cell action potential [MF], granulosa cell development [BP], membrane repolarization involved in regulation of SA node cell action potential [BP], posttranslational protein targeting to membrane [BP], voltage-gated calcium channel activity involved in regulation of cardiac muscle cell action potential [MF]
CG_ffipsc69_promoter_p_PM_12_212_10			2	0.4	1.98E-05	PPIF, LRP1, PAN3	lipoprotein transporter activity [MF], positive regulation of cytoplasmic mRNA processing body assembly [BP], negative regulation of platelet-derived growth factor receptor-beta signaling pathway [BP], regulation of proton-transporting ATPase activity, rotational mechanism [BP]
CG_ffipsc69_promoter_p_PM_12_232_9			1	0.2	6.05E-05	GLP1R, STAG3	transverse filament [CC], glucagon receptor activity [MF]
CG_ffipsc69_promoter_p_PM_16_20_10			5	1.0	2.90E-05	ACTN4	negative regulation of cellular component movement [BP], positive regulation of sodium:hydrogen antiporter activity [BP], positive regulation of pinocytosis [BP]
CG_ffipsc69_promoter_p_PM_18_17_36			4	0.8	2.68E-05	RAB8A, SLC44A2, FABP5, SYNGR1	regulation of long-term neuronal synaptic plasticity [BP], phosphatidylcholine biosynthetic process [BP]
CG_ffipsc69_promoter_p_PM_14_53_9			4	0.8	3.19E-05	BCMO1	beta-carotene 15,15'-monooxygenase activity [MF], vitamin A biosynthetic process [BP]
CG_ffipsc69_promoter_p_PM_16_41_17			2	0.4	2.06E-05	LTC4S	leukotriene-C4 synthase activity [MF]
CG_ffipsc69_promoter_p_PM_12_230_6			2	0.4	4.86E-05	PMAIP1, SERPINA5, LRP1	protein C inhibitor-PLAT complex [CC], lipoprotein transporter activity [MF], protein C inhibitor-thrombin complex [CC], protein C inhibitor-coagulation factor V complex [CC], negative regulation of mitochondrial membrane potential [BP], protein C inhibitor-TMPRSS7 complex [CC], protein C inhibitor-coagulation factor Xa complex [CC], protein C inhibitor-KLK3 complex [CC], negative regulation of platelet-derived growth factor receptor-beta signaling pathway [BP], protein C inhibitor-TMPRSS11E complex [CC], protein C inhibitor-coagulation factor XI complex [CC], protein C inhibitor-PLAU complex [CC], protein C inhibitor-plasma kallikrein complex [CC]
CG_ffipsc69_promoter_p_PM_12_287_13			3	0.6	1.98E-04	IDUA	L-iduronidase activity [MF]
CG_ffipsc69_promoter_p_PM_12_306_6			1	0.2	5.67E-05	H6PD, SMOX	norspermine:oxygen oxidoreductase activity [MF], spermine catabolic process [BP], glucose 1-dehydrogenase [NAD(P)] activity [MF], N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity [MF]
CG_ffipsc69_promoter_p_PM_12_229_7			1	0.2	6.32E-05	PPCDC, GLI2	smoothened signaling pathway involved in spinal cord motor neuron cell fate specification [BP], smoothened signaling pathway involved in ventral spinal cord interneuron specification [BP], spinal cord ventral commissure morphogenesis [BP], notochord regression [BP], phosphopantothenoylcysteine decarboxylase activity [MF]
CG_ffipsc69_promoter_p_PM_14_86_11			2	0.4	5.25E-05	BIRC5	interphase microtubule organizing center [CC]
CG_ffipsc69_promoter_p_PM_12_182_12			3	0.6	7.14E-05	S100A9, FABP5	regulation of integrin biosynthetic process [BP], fatty acid binding [MF]
CG_ffipsc69_promoter_p_PM_12_302_17			3	0.6	3.11E-05	AIP, CAT, HMBS	GAF domain binding [MF], peptidyl-pyrromethane cofactor linkage [BP], catalase activity [MF], negative regulation of cyclic-nucleotide phosphodiesterase activity [BP], hydroxymethylbilane synthase activity [MF], menopause [BP]
CG_ffipsc69_promoter_p_PM_12_27_13			2	0.4	6.52E-05	BCMO1, MED25	beta-carotene 15,15'-monooxygenase activity [MF], positive regulation of chromatin binding [BP], positive regulation of mediator complex assembly [BP], vitamin A biosynthetic process [BP]
CG_ffipsc69_promoter_p_PM_12_225_6			3	0.6	5.62E-05	CAPN3, HBP1, THTPA	autolysis [BP], thiamin-triphosphatase activity [MF], cell cycle arrest [BP], G1 to G0 transition involved in cell differentiation [BP]
CG_ffipsc69_promoter_p_PM_12_276_11			4	0.6	1.34E-04	GBA3	glycosylceramidase activity [MF], beta-glucosidase activity [MF]
CG_ffipsc69_promoter_p_PM_12_39_15			3	0.6	3.30E-04	SARS	serine-tRNA ligase activity [MF], selenocysteinyl-tRNA(Sec) biosynthetic process [BP], seryl-tRNA aminoacylation [BP]
CG_ffipsc69_promoter_p_PM_14_47_12			2	0.4	1.11E-04	GPR142, GRIN2D, PSD2	cell junction [CC]
CG_ffipsc69_promoter_p_PM_14_13_18			3	0.6	7.16E-05	ST3GAL3, FUT2, HMP19	Golgi cisterna membrane [CC]
CG_ffipsc69_promoter_p_PM_12_202_5			2	0.4	8.99E-05	FNDC1, PRMT7, NFATC1	[myelin basic protein]-arginine N-methyltransferase activity [MF], peptidyl-arginine methylation, to symmetrical-dimethyl arginine [BP], mitogen-activated protein kinase p38 binding [MF], histone methyltransferase activity (H4-R3 specific) [MF], RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription [MF], protein-arginine omega-N symmetric methyltransferase activity [MF], positive regulation of cardiac muscle cell apoptotic process [BP]
CG_ffipsc69_promoter_p_PM_16_7_13			2	0.4	5.68E-05	SPR	sepiapterin reductase activity [MF]
CG_ffipsc69_promoter_p_PM_18_2_25			4	0.8	5.07E-05	RBPJ, ALDH3A2	recombinase activity [MF], long-chain-alcohol oxidase activity [MF], long-chain-aldehyde dehydrogenase activity [MF], medium-chain-aldehyde dehydrogenase activity [MF]
CG_ffipsc69_promoter_p_PM_12_158_7			2	0.4	9.74E-05	CYP4B1, NEK6	fluorene metabolic process [BP], fluorene oxygenase activity [MF], spindle assembly [BP]
CG_ffipsc69_promoter_p_PM_12_200_6			1	0.2	1.27E-04	TALDO1	sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [MF]
CG_ffipsc69_promoter_p_PM_12_146_9			2	0.4	1.59E-04	STRA8, TFAP2C	dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis [BP], meiotic cell cycle DNA replication checkpoint [BP]
CG_ffipsc69_promoter_p_PM_14_4_24			3	0.6	2.75E-05	BHMT2, KLC1	betaine-homocysteine S-methyltransferase activity [MF], stress granule disassembly [BP]
CG_ffipsc69_promoter_p_PM_12_284_12			3	0.6	4.53E-05	PLK4, MGMT, COL15A1	collagen type XV [CC], methylated-DNA-[protein]-cysteine S-methyltransferase activity [MF], positive regulation of centriole replication [BP]
CG_ffipsc69_promoter_p_PM_12_344_5			2	0.4	1.57E-04	COL14A1, CARM1, ETFDH, PUS1	pseudouridylate synthase activity [MF], intracellular estrogen receptor signaling pathway [BP], regulation of intracellular estrogen receptor signaling pathway [BP], histone methyltransferase activity (H3-R17 specific) [MF], ligand-dependent nuclear receptor transcription coactivator activity [MF], histone H3-R17 methylation [BP], oxidoreductase activity, oxidizing metal ions with flavin as acceptor [MF], collagen type XIV [CC]
CG_ffipsc69_promoter_p_PM_12_251_10			1	0.2	1.10E-04	HSD17B2	testosterone 17-beta-dehydrogenase (NAD+) activity [MF], 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity [MF]
CG_ffipsc69_promoter_p_PM_14_29_5			2	0.4	1.50E-05	CCDC40, TRNT1	tRNA 3'-terminal CCA addition [BP], ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity [MF], CTP:3'-cytidine-tRNA cytidylyltransferase activity [MF], tRNA nucleotidyltransferase activity [MF], flagellar cell motility [BP], CTP:tRNA cytidylyltransferase activity [MF], tRNA adenylyltransferase activity [MF], tRNA 3'-end processing [BP]
CG_ffipsc69_promoter_p_PM_14_81_15			3	0.6	1.15E-04	USPL1, IVD	isovaleryl-CoA dehydrogenase activity [MF], SUMO-specific isopeptidase activity [MF], Cajal body organization [BP]
CG_ffipsc69_promoter_p_PM_12_82_8			3	0.6	6.62E-05	GLCE	UDP-glucuronate 5'-epimerase activity [MF], heparosan-N-sulfate-glucuronate 5-epimerase activity [MF]
CG_ffipsc69_promoter_p_PM_12_323_13			3	0.6	6.07E-05	DDX19B, IPO7, GCAT	glycine C-acetyltransferase activity [MF], L-threonine catabolic process to glycine [BP], nuclear pore [CC]
CG_ffipsc69_promoter_p_PM_14_9_5			3	0.6	2.54E-05	LDHC, ATP2A1	positive regulation of fast-twitch skeletal muscle fiber contraction [BP], elevation of endoplasmic reticulum calcium ion concentration [BP], relaxation of skeletal muscle [BP], lactate oxidation [BP]
CG_ffipsc69_promoter_p_PM_12_69_10			2	0.4	9.84E-05	RAD23B, B3GNT6	XPC complex [CC], beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [MF], nucleotide-excision repair, DNA damage recognition [BP], O-glycan processing, core 3 [BP]
CG_ffipsc69_promoter_p_PM_12_237_13			2	0.4	1.46E-04	WNT8A, STXBP2, ID2, SLC5A5, SLC12A5	sodium:iodide symporter activity [MF], thermosensory behavior [BP], polarity specification of anterior/posterior axis [BP], positive regulation of transcription involved in G1/S phase of mitotic cell cycle [BP], syntaxin-3 binding [MF]
CG_ffipsc69_promoter_p_PM_14_70_7			1	0.2	9.91E-05	NEIL1, TXNDC2	negative regulation of nuclease activity [BP], nutrient reservoir activity [MF]
CG_ffipsc69_promoter_p_PM_16_26_8			1	0.2	4.17E-05	SLC2A4	cellular response to osmotic stress [BP]
CG_ffipsc69_promoter_p_PM_14_39_5			1	0.2	1.12E-04	LTC4S, E4F1	leukotriene-C4 synthase activity [MF], regulation of mitotic cell cycle, embryonic [BP]
CG_ffipsc69_promoter_p_PM_12_255_19			2	0.4	9.94E-05	CALCOCO2, PDE3B, ITPA, NUDT16, ATP6V0A1, ZP3, FGD3	Golgi apparatus [CC], dITP diphosphatase activity [MF]
CG_ffipsc69_promoter_p_PM_12_194_11			2	0.4	2.60E-04	KIF19, FUK, DUT	dUTP diphosphatase activity [MF], dUTP metabolic process [BP], fucokinase activity [MF], plus-end specific microtubule depolymerization [BP], dUMP biosynthetic process [BP], axonemal microtubule depolymerization [BP]
CG_ffipsc69_promoter_p_PM_12_40_11			2	0.4	6.66E-05	NECAP1	clathrin vesicle coat [CC]
CG_ffipsc69_promoter_p_PM_12_72_10			2	0.4	3.64E-05	SKIL, IFRD1, SIVA1	CD27 receptor binding [MF], adult somatic muscle development [BP], lymphocyte homeostasis [BP]
CG_ffipsc69_promoter_p_PM_16_10_7			1	0.2	1.49E-04	KDM1B, RBM4, DNMT3B	histone demethylase activity (H3-monomethyl-K4 specific) [MF], circadian regulation of translation [BP], IRES-dependent translational initiation [BP], cap-independent translational initiation [BP], DNA methylation [BP], pre-mRNA intronic pyrimidine-rich binding [MF], regulation of gene expression by genetic imprinting [BP]
CG_ffipsc69_promoter_p_PM_12_32_8			2	0.4	6.58E-05	MSMO1	C-4 methylsterol oxidase activity [MF]
CG_ffipsc69_promoter_p_PM_12_172_5			1	0.2	2.84E-05	IL1RN	interleukin-1 Type II receptor antagonist activity [MF], interleukin-1 Type I receptor antagonist activity [MF]
CG_ffipsc69_promoter_p_PM_12_166_12			2	0.4	3.58E-04	NTF3	glial cell fate determination [BP]
CG_ffipsc69_promoter_p_PM_12_308_12			5	0.8	5.79E-05	RPE	ribulose-phosphate 3-epimerase activity [MF]
CG_ffipsc69_promoter_p_PM_12_60_8			3	0.4	1.69E-04	H6PD	glucose 1-dehydrogenase [NAD(P)] activity [MF], 6-phosphogluconolactonase activity [MF], glucose-6-phosphate dehydrogenase activity [MF]
CG_ffipsc69_promoter_p_PM_12_185_12			2	0.4	1.67E-04	BCAM	laminin receptor activity [MF]
CG_ffipsc69_promoter_p_PM_14_38_16			3	0.6	6.69E-05	PCSK9, SCYL2, PLK4, KDM1A	negative regulation of receptor recycling [BP], negative regulation of histone H3-K4 methylation [BP], lysosomal transport [BP], positive regulation of receptor internalization [BP], positive regulation of centriole replication [BP], regulation of primitive erythrocyte differentiation [BP]
CG_ffipsc69_promoter_p_PM_14_7_18			2	0.4	7.34E-05	PRKAR2B, WRAP53, PHACTR4	protein phosphatase type 1 activator activity [MF], response to antipsychotic drug [BP], closure of optic fissure [BP], positive regulation of catalytic activity [BP], negative regulation of integrin-mediated signaling pathway [BP], telomere formation via telomerase [BP], response to clozapine [BP]
CG_ffipsc69_promoter_p_PM_12_186_6			2	0.4	4.75E-05	TALDO1	sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [MF]
CG_ffipsc69_promoter_p_PM_12_92_7			1	0.2	4.71E-05	NDST1	heparin biosynthetic process [BP], embryonic neurocranium morphogenesis [BP], [heparan sulfate]-glucosamine N-sulfotransferase activity [MF]
CG_ffipsc69_promoter_p_PM_12_66_6			2	0.4	6.05E-05	PARVB	establishment or maintenance of cell polarity regulating cell shape [BP]
CG_ffipsc69_promoter_p_PM_12_101_4			2	0.4	6.56E-05	ARPC2	AP-1 adaptor complex binding [MF], Arp2/3 complex binding [MF]
CG_ffipsc69_promoter_p_PM_12_283_8			2	0.4	6.93E-05	MDH1, IRAK3	positive regulation of macrophage tolerance induction [BP], diiodophenylpyruvate reductase activity [MF], L-malate dehydrogenase activity [MF]
CG_ffipsc69_promoter_p_PM_14_33_5			1	0.2	1.63E-05	GTPBP4	negative regulation of collagen binding [BP]
CG_ffipsc69_promoter_p_PM_12_126_12			3	0.6	1.27E-04	PTPMT1	phosphatidylglycerophosphatase activity [MF]
CG_ffipsc69_promoter_p_PM_12_13_12			2	0.4	3.80E-04	KRTAP5-5, KRTAP10-7	keratin filament [CC]
CG_ffipsc69_promoter_p_PM_12_243_7			3	0.6	5.59E-05	KIT	melanocyte migration [BP], stem cell factor receptor activity [MF], melanocyte adhesion [BP]
CG_ffipsc69_promoter_p_PM_12_70_9			1	0.2	1.87E-05	XRCC5	Ku70:Ku80 complex [CC]
CG_ffipsc69_promoter_p_PM_12_43_5			2	0.4	7.47E-05	AFMID	arylformamidase activity [MF]
CG_ffipsc69_promoter_p_PM_12_137_12			2	0.4	1.34E-04	KIF19	plus-end specific microtubule depolymerization [BP], axonemal microtubule depolymerization [BP]
CG_ffipsc69_promoter_p_PM_12_322_5			3	0.6	6.30E-05	CD40LG, IRF4, MALT1, IFIT3, SERPINE1, BICD1, ENTPD6	negative regulation of vascular wound healing [BP], positive regulation of interleukin-13 biosynthetic process [BP], negative regulation of phospholipase C activity [BP], host cell viral assembly compartment [CC], positive regulation of leukotriene production involved in inflammatory response [BP], B-1 B cell differentiation [BP], proteinase activated receptor binding [MF], negative regulation of apoptotic process [BP], positive regulation of receptor-mediated endocytosis [BP], regulation of proteinase activated receptor activity [BP], defense response [BP], guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity [MF], negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway [BP]
CG_ffipsc69_promoter_p_PM_12_289_7			1	0.2	9.92E-05	MSRA	peptide-methionine (S)-S-oxide reductase activity [MF]
CG_ffipsc69_promoter_p_PM_14_25_11			1	0.2	6.41E-05	ARHGEF16, ADSSL1	adenylosuccinate synthase activity [MF], 'de novo' AMP biosynthetic process [BP], activation of Cdc42 GTPase activity [BP]
CG_ffipsc69_promoter_p_PM_18_7_61			5	0.8	3.35E-05	ARFGEF2, RBBP4, HMGA1	symmetric synapse [CC], chromatin assembly [BP], oncogene-induced senescence [BP], chromatin remodeling [BP]
CG_ffipsc69_promoter_p_PM_18_11_20			4	0.8	7.27E-05	PSMA6, NANOS3, WTIP	cytoplasmic mRNA processing body [CC]
CG_ffipsc69_promoter_p_PM_12_78_20			2	0.4	4.76E-05	ME2, ITGAM	malate dehydrogenase (decarboxylating) activity [MF], microglia development [BP]
CG_ffipsc69_promoter_p_PM_12_8_10			2	0.4	6.67E-05	S100A9, ADORA2A	positive regulation of acetylcholine secretion [BP], astrocyte activation [BP], type 5 metabotropic glutamate receptor binding [MF], neutrophil aggregation [BP], inflammatory response [BP], positive regulation of inflammatory response [BP]
CG_ffipsc69_promoter_p_PM_14_48_5			2	0.4	1.04E-05	CD4	protein palmitoleylation [BP], induction by virus of host cell-cell fusion [BP]
CG_ffipsc69_promoter_p_PM_12_201_8			3	0.6	1.37E-04	ANXA3, AR, STAB1, RGCC, EPHB2	angiogenesis [BP], negative regulation of integrin biosynthetic process [BP], negative regulation of exit from mitosis [BP], regulation of M/G1 transition of mitotic cell cycle [BP], positive regulation of sequence-specific DNA binding transcription factor activity [BP], neutrophil degranulation [BP], male somatic sex determination [BP], negative regulation of angiogenesis [BP], activation of prostate induction by androgen receptor signaling pathway [BP]
CG_ffipsc69_promoter_p_PM_18_26_23			3	0.6	4.13E-05	HEY2, F2R	tricuspid valve morphogenesis [BP], umbilical cord morphogenesis [BP], negative regulation of transcription initiation from RNA polymerase II promoter [BP], negative regulation of cardiac vascular smooth muscle cell differentiation [BP], negative regulation of renin secretion into blood stream [BP], protein-DNA complex assembly [BP], negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation [BP], tricuspid valve formation [BP]
CG_ffipsc69_promoter_p_PM_14_10_40			10	1.0	7.87E-05	VIL1, BMPR2, EPB41L5	positive regulation of epithelial cell migration [BP]
CG_ffipsc69_promoter_p_PM_18_1_80			4	0.8	3.93E-05	MDM2, FDFT1, ACER3	cellular response to vitamin B1 [BP], phytosphingosine biosynthetic process [BP], squalene synthase activity [MF], cellular response to UV-C [BP], farnesyl-diphosphate farnesyltransferase activity [MF], phytoceramidase activity [MF]
CG_ffipsc69_promoter_p_PM_12_176_15			2	0.4	3.29E-05	CYP46A1, BGLAP	regulation of bone resorption [BP], cholesterol 24-hydroxylase activity [MF]
CG_ffipsc69_promoter_p_PM_12_33_16			4	0.6	3.47E-05	ASPA	aspartoacylase activity [MF]
CG_ffipsc69_promoter_p_PM_18_35_29			3	0.6	4.08E-05	PIN1, SPRY1	negative regulation of ERK1 and ERK2 cascade [BP]
CG_ffipsc69_promoter_p_PM_12_91_4			2	0.4	6.97E-05	RANBP1, KIF2C, KIF25	kinesin complex [CC], positive regulation of mitotic centrosome separation [BP]
CG_ffipsc69_promoter_p_PM_12_57_6			2	0.4	1.21E-04	ALDH3A2, UBE2B, SNRPC, TRIM24	U1 snRNP [CC], positive regulation of reciprocal meiotic recombination [BP], medium-chain-aldehyde dehydrogenase activity [MF], long-chain-aldehyde dehydrogenase activity [MF], perichromatin fibrils [CC], negative regulation of histone phosphorylation [BP], long-chain-alcohol oxidase activity [MF], phytol metabolic process [BP], regulation of protein stability [BP]
CG_ffipsc69_promoter_p_PM_12_196_14			1	0.2	1.85E-05	FNTB	protein farnesyltransferase complex [CC]
CG_ffipsc69_promoter_p_PM_12_169_9			2	0.4	2.90E-04	SACM1L, TNKS2	phosphatidylinositol-4-phosphate phosphatase activity [MF], protein auto-ADP-ribosylation [BP], positive regulation of telomere maintenance via telomerase [BP]
CG_ffipsc69_promoter_p_PM_12_355_11			4	0.6	6.59E-05	KIF19, LDHC, ATP5D	plus-end specific microtubule depolymerization [BP], ATP biosynthetic process [BP], axonemal microtubule depolymerization [BP], lactate oxidation [BP]
CG_ffipsc69_promoter_p_PM_12_152_10			2	0.4	1.09E-04	SLC7A2	high affinity arginine transmembrane transporter activity [MF]
CG_ffipsc69_promoter_p_PM_12_266_4			3	0.6	9.29E-05	UROD	uroporphyrinogen decarboxylase activity [MF]
CG_ffipsc69_promoter_p_PM_18_24_22			2	0.4	3.42E-05	MUM1, SRSF3, DDX19B, RANBP17, AGFG1, ANKLE1	chromatin organization [BP], mRNA export from nucleus [BP], nuclear pore [CC], mRNA transport [BP], nuclear envelope [CC]
CG_ffipsc69_promoter_p_PM_16_51_10			1	0.2	5.41E-05	L3MBTL1	SAM domain binding [MF]
CG_ffipsc69_promoter_p_PM_16_55_8			3	0.6	1.17E-05	PIPOX	L-lysine catabolic process to acetyl-CoA via L-pipecolate [BP], L-pipecolate oxidase activity [MF], sarcosine oxidase activity [MF]
CG_ffipsc69_promoter_p_PM_12_21_10			2	0.4	3.03E-05	PDZK1, SPO11	scavenger receptor binding [MF], zygotene [BP]
CG_ffipsc69_promoter_p_PM_12_109_7			2	0.4	2.54E-05	SMCHD1, FXYD5	inactivation of X chromosome by DNA methylation [BP], negative regulation of calcium-dependent cell-cell adhesion [BP]
CG_ffipsc69_promoter_p_PM_18_8_20			5	0.8	3.96E-05	SCP2, ARPC1A	regulation of actin filament polymerization [BP], protein localization to plasma membrane [BP], propanoyl-CoA C-acyltransferase activity [MF], lipid hydroperoxide transport [BP], long-chain fatty acyl-CoA binding [MF], positive regulation of intracellular cholesterol transport [BP], oleic acid binding [MF]
CG_ffipsc69_promoter_p_PM_14_35_4			1	0.2	3.79E-05	FZD1	canonical Wnt receptor signaling pathway involved in mesenchymal stem cell differentiation [BP], autocrine signaling [BP], canonical Wnt receptor signaling pathway involved in osteoblast differentiation [BP]